Ready for some good news? A new study on the potential COVID-19 treatment drug remdesivir from Gilead Sciences Inc has yielded some "significant positive effects" among infected individuals. The international study, described as a randomized placebo control trial and sponsored by The National Allergy Institute of Infectious Diseases, began on February 21.
“[The study data] shows that remdesivir has a clear-cut, significant positive effect in diminishing the time to recovery;” National Allergy Institute of Infectious Diseases Director Dr. Anthony Fauci revealed at the White House on Wednesday.
The primary result, Dr. Fauci explained, was the 31 percent improvement in recovery time, as some patients on the drug recovered a few days ahead of schedule.
Dr. Fauci on the clinical trial for potential coronavirus treatment drug remdesivir:
— NBC News (@NBCNews) April 29, 2020
“[The study data] shows that remdesivir has a clear-cut, significant positive effect in diminishing the time to recovery;” says remdesivir improved recovery time from 15 days to 11 days. pic.twitter.com/1WNCO3c5hI
Gilead said its experimental antiviral drug, remdesivir, had met the main goal of a trial testing it in COVID-19 patients https://t.co/5eiiHQgDLS
— Reuters (@Reuters) April 29, 2020
Dr. Anthony Fauci touts the results of a trial examining remdesivir, an experimental drug treatment for the novel coronavirus, calling it “good news.”
— ABC News (@ABC) April 29, 2020
The trial has not yet been peer-reviewed but is being submitted to a journal for review, Fauci says. https://t.co/EbWH2wyNAN pic.twitter.com/v3djerUL3l
Recommended
WATCH: Dr. Anthony Fauci's full comments on the "quite good news" regarding the trial of Gilead's remdesivir treatment for coronavirus. https://t.co/NoszTy7YcN pic.twitter.com/rSjtrRyuee
— CNBC Now (@CNBCnow) April 29, 2020
BREAKING: the drug Remdesivir "has a clear cut significant positive effect in diminishing the time to recovery" for COVID19 patients, says Dr. Anthony Fauci. It blocks an enzyme the virus uses.
— David Begnaud (@DavidBegnaud) April 29, 2020
Fauici: there was an ethical obligation to let people know.
pic.twitter.com/X7fScFNY0g
In addition, the mortality rate "trended towards being better" at 8 percent versus 11 percent, the doctor added.
While Fauci said these improvements seem a bit modest, it proves a few "important" things. The trial has proven that a drug can block this virus. In particular, it appears to be blocking an enzyme that the virus uses. Fauci called it "positive news."
Wednesday's development reminded Dr. Fauci of the period during the AIDS epidemic in 1986 when medical professionals were struggling to find a drug treatment. They started with AZT, which produced only modest effects. But they "kept building" on it every year until they developed a more effective treatment, the doctor recalled. Dr. Deborah Birx, who was also on the frontlines in the fights against AIDS, nodded as Fauci made the comparison.
Dr. Fauci and his team will be immediately putting this new research to work. The next step, he explained, is to compare the combination of remdesivir with an anti-inflammatory drug they're also testing.
Editor's Note: Want to support Townhall so we can keep telling the truth about China and the virus they unleashed on the world? Join Townhall VIP and use the promo code WUHAN to get 25% off VIP membership!
Join the conversation as a VIP Member